Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reverse genetic approaches for the development of Zika vaccines and therapeutics

Current Opinion in Virology(2020)10.1016/j.coviro.2020.05.002Source: DataRank Database

Reverse genetic approaches for the development of Zika vaccines and therapeutics is a research paper published in Current Opinion in Virology (2020). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.51)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Coleman Baker ORCID,Pei‐Yong Shi ORCID,Camila R. Fontes-Garfias ORCID

Live enrichment

PubMed:32563700 PMC:PMC9373025 OpenAlex:https://openalex.org/W3036345436

NCATS NIH HHS

Grant: UL1 TR001439

NIAID NIH HHS

Grant: R01 AI127744

NIAID NIH HHS

Grant: R01 AI134907

NIAID NIH HHS

Grant: R41 AI136126

NIAID NIH HHS

Grant: R43 AI145617

NIAID NIH HHS

Grant: U19 AI142759

NIAID NIH HHS

Grant: T32 AI007526

National Institutes of Health

Grant: 5R41AI136126-02

Discovery of Zika virus therapeutics using a replicon assay

National Institutes of Health

Grant: 5U19AI142759-04

Antiviral Drug Discovery and Development Center (AD3C)

National Institutes of Health

Grant: 1R43AI145617-01A1

Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats

National Institutes of Health

Grant: 5UL1TR001439-07

UTMB Clinical and Translational Science Award

National Institutes of Health

Grant: 3R01AI134907-03S2

A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery

National Institutes of Health

Grant: 5R01AI127744-05

Revolutionary Eilat-based Chikungunya Vaccine Vector

National Institutes of Health

Grant: 5T32AI007526-10

Emerging and Tropical Infectious Diseases

National Institutes of Health

FWCI

0.51

Citation Percentile

0.7%

Citation Trend

2020

2021

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9373025

publisherhttps://api.elsevier.com/content/article/PII:S1879625720300237?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1879625720300237?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.coviro.2020.05.002

Fields of Study

Mosquito-borne diseases and controlViral Infections and VectorsMalaria Research and Control0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntiviral AgentsGuillain-Barre SyndromeHumansMiceRNA, ViralReverse GeneticsViral VaccinesZika VirusZika Virus Infection

MeSH Terms

Zika Virus InfectionZika VirusAnimalsAntiviral AgentsHumansRNA, ViralViral VaccinesGuillain-Barre SyndromeMiceReverse Genetics

Keywords

Zika virusVirologyPublic healthBiologyGuillain-Barre syndromeGlobal healthVirusImmunologyMedicineZika Virus InfectionViral VaccinesAntiviral AgentsReverse GeneticsMiceAnimalsHumansRNA, Viral

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being